Skip to main content

Diabetes complications and comorbidities: Ketoacidosis

medwireNews

04-05-2023 | Flash glucose monitoring | News

Reduced acute complications for young people using CGM

Data from the DPV cohort show a reduced risk for severe hypoglycemia and diabetic ketoacidosis among children and young people with type 1 diabetes using continuous glucose monitoring rather than self-monitored blood glucose.

10-06-2022 | COVID-19 | News

Pandemic ‘exacerbated’ existing trends in ketoacidosis at diabetes diagnosis

Analysis of childhood type 1 diabetes diagnoses across 13 countries indicates that the conditions created by the COVID-19 pandemic worsened pre-existing increasing trends in ketoacidosis at diagnosis.

09-20-2022 | EASD 2022 | Conference coverage | News

Freestyle Libre cuts acute complication risk in insulin-treated type 2 diabetes

People taking basal insulin to treat type 2 diabetes experience a significant reduction in the risk for acute complications, which is sustained for at least 2 years after initiating use of the Freestyle Libre, say French researchers.

05-18-2022 | Empagliflozin | News

Pros and cons with empagliflozin addition to closed-loop insulin

Adding daily empagliflozin to closed-loop insulin delivery improves time in range but also increases ketone levels in people with type 1 diabetes, shows a randomized trial.

04-26-2022 | Ketoacidosis | News

Subcutaneous insulin protocol feasible for DKA

Implementing a subcutaneous insulin protocol for the treatment of diabetic ketoacidosis significantly reduces intensive care admissions and readmission to hospital within 30 days of discharge without increasing hypoglycemia, research shows.

Pregnant woman with diabetes

11-24-2021 | Ketoacidosis | News

DKA in pregnancy linked to high perinatal mortality rates

Diabetic ketoacidosis affects around one in 60 pregnant women with type 1 diabetes and is associated with “exceptionally high” perinatal mortality rates, shows research.

11-15-2021 | Transitions of care | News

Acute diabetes complications rise during transition to adult care

Young people with type 1 diabetes are at increased risk for hospitalization for acute complications at the time of transition from pediatric to adult care, say researchers.

09-28-2021 | EASD 2021 | Conference coverage | News

DKA presentation similar for type 1 and type 2 diabetes

Diabetic ketoacidosis is three times more common with type 1 diabetes than with type 2 diabetes, but episode presentation and severity are similar between the two groups, show data presented at the virtual 57th EASD Annual Meeting.

Doctors and nurses taking care of patients in ICU

09-06-2021 | COVID-19 | News

Pandemic rise in DKA admissions conceals opposing trends

Researchers find the increase in hospital admissions for diabetic ketoacidosis in England during the COVID-19 pandemic was caused by additional admissions of people with new-onset or type 2 diabetes.

07-27-2021 | Ketoacidosis | News

DKA prevention needs reinforcing amid increasing incidence rates

The incidence of diabetic ketoacidosis has risen gradually since 2004, with sharper increases occurring among the oldest and most socioeconomically deprived groups, shows an analysis of data from Scotland.

03-25-2021 | Ketoacidosis | News

Mortality twice as likely with early DKA readmission

Readmission to hospital within a month of admission for diabetic ketoacidosis is common and associated with an increased mortality risk, say researchers.

01-29-2021 | Ketoacidosis | News

Mental health issues may contribute to recurrent DKA risk

Researchers find that people with recurrent diabetic ketoacidosis have an increased rate of mental health problems such as diabetes distress and personality disorder.

01-08-2021 | Ketoacidosis | News

DKA predictors could facilitate targeted SGLT2 inhibitor use in type 1 diabetes

Increased BMI and insulin resistance are important predictors of diabetic ketoacidosis risk among people with type 1 diabetes using SGLT2 inhibitors, say the authors of a meta-analysis and meta-regression.

01-07-2021 | Hypoglycemia | News

Any residual C-peptide offers protection for people with type 1 diabetes

Any amount of residual C-peptide is protective against some type 1 diabetes complications, show findings from a large, population-based study.

12-10-2020 | Children | News

DKA linked to concurrent kidney, brain injury in children

Acute kidney injury is common in children with diabetic ketoacidosis and is associated with circulatory volume depletion, greater acidosis, and signs of cerebral injury, US study data show.

10-14-2020 | Ketoacidosis | News

DKA linked to cognitive alterations in children with type 1 diabetes

Research shows moderate or severe diabetic ketoacidosis is associated with lower IQ and reduced short- and long-term memory in children with type 1 diabetes, with some impairment seen even in newly diagnosed children.

07-31-2020 | Ketoacidosis | News

DKA risk increased with SGLT2 inhibitor use, but low overall

A large population-based study supports an increased risk for diabetic ketoacidosis for users of SGLT2 inhibitors compared with DPP-4 inhibitors, although the absolute risk remains low.

07-22-2020 | COVID-19 | News

COVID-19 pandemic linked to increased ketoacidosis at pediatric type 1 diabetes diagnosis

Researchers have identified a marked increase in the proportion of children and adolescents who have diabetic ketoacidosis at the point of type 1 diabetes diagnosis during the COVID-19 pandemic.

07-20-2020 | Flash glucose monitoring | News

More evidence for acute complication reduction with real-world flash glucose monitoring

UK audit data confirm multiple benefits linked to real-world use of flash glucose monitoring including reduced paramedic callouts and hospital admissions for acute diabetes complications.

Abbott Freestyle Libre

06-14-2020 | ADA 2020 | Conference coverage | News

​​​​​​​FreeStyle Libre use linked to substantial reduction in acute diabetes complications

Real-world data presented at the virtual ADA 80th Scientific Sessions highlight the benefits of the FreeStyle Libre continuous glucose monitoring system in reducing acute complications in people with type 1 or type 2 diabetes.